+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Thrombin Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017-2025

  • ID: 4851454
  • Report
  • January 2018
  • Region: Global
  • 162 pages
  • Transparency Market Research
1 of 2

Global Thrombin Market: Overview

This report on thrombin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacturing and commercialization of thrombin products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global thrombin market with respect to the leading market segments based on major product segment, dosage form segment, and end users segment.

Global Thrombin Market: Key Segments

Based on the product type, the thrombin market has been segmented into bovine thrombin, human thrombin and recombinant thrombin. Each of the market segments have been extensively analyzed based on the market related factors such as increasing demand of thrombin products worldwide, and technological advancement. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the thrombin market and could influence the market in near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global thrombin market.

Global Thrombin Market: Regional Outlook

Geographically, thrombin market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of World. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global thrombin market.

Companies Mentioned in Report

The report also profiles key players operating in the thrombin market which are Johnson & Johnson, Pfizer, Inc., Mallinckrodt Pharmaceuticals, Shanghai RAAS blood products co., Ltd., Japan Blood Products Organization and Mochida Pharmaceutical Co., Ltd.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1 Report Scope
1.2 Market Segmentation
1.3 Research Highlights

2. Assumptions and Research Methodology
2.1 Assumptions
2.2 Acronyms Used
2.3 Research Methodology

3. Executive Summary

4. Market Overview
4.1 Product Overview
4.2 Key Industry Developments
4.3 Global Thrombin Market Size (US$ Mn) Forecast
4.4 Market Opportunity Map
4.5 Market Indicators
4.6 Porter’s Analysis
4.7 Global Thrombin Market Outlook

5. Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Features of Ideal Hemostat at a glance
5.6 Key Brand Analysis
5.7 Regulatory Scenario

6. Global Thrombin Market Analysis, by Product
6.1 Key Findings
6.2 Introduction
6.3 Global Thrombin Market Value Share Analysis, by Product
6.4 Global Thrombin Market Forecast, by Product
6.4.1. Bovine Thrombin
6.4.2. Human Thrombin
6.4.3. Recombinant Thrombin
6.5 Global Thrombin Market Analysis, by Product
6.6 Global Thrombin Market Attractiveness Analysis, by Product

7. Global Thrombin Market Analysis, by Dosage Form
7.1 Key Findings
7.2 Introduction
7.3 Global Thrombin Market Value Share Analysis, by Dosage Form
7.4 Global Thrombin Market Forecast, by Dosage Form
7.4.1. Powder Forms
7.4.2. Solution Forms
7.4.3. Others
7.5 Global Thrombin Market Analysis, by Dosage Form
7.6 Global Thrombin Market Attractiveness Analysis, by Dosage Form

8. Global Thrombin Market Analysis, by End-user
8.1 Key Findings
8.2 Introduction
8.3 Global Thrombin Market Value Share Analysis, by End-user
8.4 Global Thrombin Market Forecast, by End-user
8.4.1. Hospitals
8.4.2. Diagnostics Centers & Clinics
8.4.3. Academics and Research Institutes
8.5 Global Thrombin Market Analysis, by End-user
8.6 Global Thrombin Market Attractiveness Analysis, by End-user

9. Thrombin Market Analysis, by Region
9.1 Global Thrombin Market Scenario
9.2 Introduction
9.3 Global Thrombin Market Value Share Analysis, by Region
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacific
9.3.4 Rest of the World
9.4 Global Thrombin Market Forecast, by Region
9.5 Global Thrombin Market Attractiveness Analysis, by Region

10. North America Thrombin Market Analysis
10.1 Key Findings
10.2 North America Thrombin Market Overview
10.3 North America Thrombin Market Value Share Analysis, by Country
10.4 North America Thrombin Market Forecast, by Country
10.4.1. U.S.
10.4.2. Canada
10.5 North America Thrombin Market Value Share Analysis, by Product
10.6 North America Thrombin Market Forecast, by Product
10.7 North America Thrombin Market Value Share Analysis, by Dosage Form
10.8 North America Thrombin Market Forecast, by Dosage Form
10.9 North America Thrombin Market Value Share Analysis, by End-user
10.10 North America Thrombin Market Forecast, by End-user
10.11 North America Thrombin Market Attractiveness Analysis

11. Europe Thrombin Market Analysis
11.1 Key Findings
11.2 Europe Thrombin Market Overview
11.3 Europe Thrombin Market Value Share Analysis, by Country
11.4 Europe Thrombin Market Forecast, by Country
11.4.1 Germany
11.4.2 U.K.
11.4.3 France
11.4.4 Italy
11.4.5 Spain
11.4.6 Rest of the Europe
11.5 Europe Thrombin Market Value Share Analysis, by Product
11.6 Europe Thrombin Market Forecast, by Product
11.7 Europe Thrombin Market Value Share Analysis, by Dosage Form
11.8 Europe Thrombin Market Forecast, by Dosage Form
11.9 Europe Thrombin Market Value Share Analysis, by End-user
11.10 Europe Thrombin Market Forecast, by End-user
11.11 Europe Thrombin Market Attractiveness Analysis

12. Asia Pacific Thrombin Market Analysis
12.1 Key Findings
12.2 Asia Pacific Thrombin Market Overview
12.3 Asia Pacific Thrombin Market Value Share Analysis, by Country
12.4 Asia Pacific Thrombin Market Forecast, by Country
12.4.1 Japan
12.4.2 China
12.4.3 Australia & New Zealand
12.4.4 Rest of Asia Pacific
12.5 Asia Pacific Thrombin Market Value Share Analysis, by Product
12.6 Asia Pacific Thrombin Market Forecast, by Product
12.7 Asia Pacific Thrombin Market Value Share Analysis, by Dosage Form
12.8 Asia Pacific Thrombin Market Forecast, by Dosage Form
12.9 Asia Pacific Thrombin Market Value Share Analysis, by End-user
12.10 Asia Pacific Thrombin Market Forecast, by End-user
12.11 Asia Pacific Thrombin Market Attractiveness Analysis

13. Rest of the World Thrombin Market Analysis
13.1 Key Findings
13.2 Rest of the World Thrombin Market Overview
13.3 Rest of the World Thrombin Market Value Share Analysis, by Country
13.5 Rest of the World Thrombin Market Value Share Analysis, by Product
13.6 Rest of the World Thrombin Market Forecast, by Product
13.7 Rest of the World Thrombin Market Value Share Analysis, by Dosage Form
13.8 Rest of the World Thrombin Market Forecast, by Dosage Form
13.9 Rest of the World Thrombin Market Value Share Analysis, by End-user
13.10 Rest of the World Thrombin Market Forecast, by End-user
13.11 Rest of the World Thrombin Market Attractiveness Analysis

14. Competition Landscape
14.1 Competition Matrix
14.2 Thrombin Market: Heat Map Analysis by Company
14.3 Company Profiles
14.3.1 Johnson & Johnson Services, Inc.
14.3.1.1Company Details
14.3.1.1 Business Overview
14.3.1.2 Financial Overview
14.3.1.3 Strategic Overview
14.3.1.4 SWOT Analysis
14.3.2 Pfizer, Inc.
14.3.2.1 Company Details
14.3.2.2 Business Overview
14.3.2.3 Financial Overview
14.3.2.4 Strategic Overview
14.3.2.5 SWOT Analysis
14.3.3 Mallinckrodt Pharmaceuticals
14.3.3.1 Company Details
14.3.3.2 Business Overview
14.3.3.3 Financial Overview
14.3.3.4 Strategic Overview
14.3.3.5 SWOT Analysis
14.3.4 Shanghai RAAS blood products co., Ltd.
14.3.4.1 Company Details
14.3.4.2 Business Overview
14.3.4.3 Financial Overview
14.3.4.4 Strategic Overview
14.3.4.5 SWOT Analysis
14.3.5 Japan Blood Products Organization
14.3.5.1 Company Details
14.3.5.2 Business Overview
14.3.5.3 Strategic Overview
14.3.5.4 SWOT Analysis
14.3.6 Mochida Pharmaceutical Co., Ltd.
14.3.6.1 Company Details
14.3.6.2 Business Overview
14.3.6.3 Financial Overview
14.3.6.4 Strategic Overview
14.3.6.5 SWOT Analysis
14.3.7 BIOFAC A/S
14.3.7.1 Company Details
14.3.7.2 Business Overview
14.3.7.3 Strategic Overview
14.3.7.4 SWOT Analysis
14.3.8 Biomed-Lublin S.A.
14.3.8.1 Company Details
14.3.8.2 Business Overview
14.3.8.3 Financial Overview
14.3.8.4 Strategic Overview
14.3.8.5 SWOT Analysis
14.3.9 Hualan Biological Engineering, Inc.
14.3.9.1 Company Details
14.3.9.2 Business Overview
14.3.9.3 Strategic Overview
14.3.9.4 SWOT Analysis
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll